Literature DB >> 1531182

Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.

P Shah1, L Dhurjon, T Metcalfe, J M Gibson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1531182      PMCID： PMC1880919          DOI： 10.1136/bmj.304.6818.40

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Nebulised ipratropium bromide and salbutamol causing closed-angle glaucoma.

Authors:  G E Packe; R M Cayton; N Mashhoudi
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

2.  The effect of nebulized bronchodilator therapy on intraocular pressures in patients with glaucoma.

Authors:  L Kalra; M F Bone
Journal:  Chest       Date:  1988-04       Impact factor: 9.410

3.  Ipratropium bromide induced angle closure glaucoma.

Authors:  J T Malani; G M Robinson; E L Seneviratne
Journal:  N Z Med J       Date:  1982-10-27
  3 in total
  14 in total

Review 1.  Non-steroidal drug-induced glaucoma.

Authors:  M R Razeghinejad; M J Pro; L J Katz
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

2.  Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.

Authors:  D M Humphreys
Journal:  BMJ       Date:  1992-02-01

3.  Selecting and using nebuliser equipment.

Authors:  A H Kendrick; E C Smith; R S Wilson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 4.  Nebulisers for the elderly.

Authors:  J C Pounsford
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

5.  Mydriasis due to self-administered inhaled ipratropium bromide.

Authors:  David W Bond; Harish Vyas; Helen E Venning
Journal:  Eur J Pediatr       Date:  2002-03       Impact factor: 3.183

6.  Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol.

Authors:  Mehmet Kola; Dilek Hacıoğlu; Hidayet Erdöl; Adem Türk
Journal:  Int Ophthalmol       Date:  2017-02-06       Impact factor: 2.031

Review 7.  Drug-induced ocular disorders.

Authors:  Junping Li; Ramesh C Tripathi; Brenda J Tripathi
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 8.  Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

Review 9.  Drug-induced glaucomas: mechanism and management.

Authors:  Ramesh C Tripathi; Brenda J Tripathi; Chris Haggerty
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat soft mist inhaler: findings from two dose-ranging studies in healthy men.

Authors:  Ulrich Feifel; Gudrun Wallenstein; Karl-Ludwig Rominger; Dirk Trommeshauser; Juliane Platz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.